What Happened?
Toronto, ON-based Khiron Resigned Helen Bellwood as Chief Financial Officer
About the Company
Khiron Life Sciences Corp. is positioned to be the dominant integrated medical cannabis company in Latin America. Khiron has core operations in Colombia and is fully licensed in the country for the cultivation, production, domestic distribution, and international export of both THC (tetrahydrocannabinol) and CBD (cannabidiol) medical cannabis. With a focused regional strategy and patient oriented approach, the company combines global scientific expertise, agricultural advantages, branded product market entrance experience and education to drive prescription and brand loyalty to address priority medical conditions such as chronic pain, epilepsy, depression and anxiety in the Latin American market of over 620 million people.
About the Person
Helen Bellwood is Chief Financial Officer at Khiron. Previously, Helen held various senior HR leadership roles in the industry.
Info Source
News
Short Profile